These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35882940)
1. Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes. Takahashi H; Nagoshi T; Kimura H; Tanaka Y; Yasutake R; Oi Y; Yoshii A; Tanaka TD; Kashiwagi Y; Yoshimura M Sci Rep; 2022 Jul; 12(1):12740. PubMed ID: 35882940 [TBL] [Abstract][Full Text] [Related]
2. The thermogenic actions of natriuretic peptide in brown adipocytes: The direct measurement of the intracellular temperature using a fluorescent thermoprobe. Kimura H; Nagoshi T; Yoshii A; Kashiwagi Y; Tanaka Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M Sci Rep; 2017 Oct; 7(1):12978. PubMed ID: 29021616 [TBL] [Abstract][Full Text] [Related]
3. Thyroid Hormone Metabolite 3-Iodothyronamine (T1AM) Alleviates Hypoxia/Reoxygenation-Induced Cardiac Myocyte Apoptosis via Akt/FoxO1 Pathway. Zhou H; Hu B; Liu X Med Sci Monit; 2020 Mar; 26():e923195. PubMed ID: 32162616 [TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399 [TBL] [Abstract][Full Text] [Related]
5. Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM). Haiyan Z; Bailong H; Bei Z; Yiming W; Xingde L Biomed Res Int; 2020; 2020():1302453. PubMed ID: 32685439 [TBL] [Abstract][Full Text] [Related]
6. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes. Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620 [TBL] [Abstract][Full Text] [Related]
7. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. Chiellini G; Frascarelli S; Ghelardoni S; Carnicelli V; Tobias SC; DeBarber A; Brogioni S; Ronca-Testoni S; Cerbai E; Grandy DK; Scanlan TS; Zucchi R FASEB J; 2007 May; 21(7):1597-608. PubMed ID: 17284482 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone. Cumero S; Fogolari F; Domenis R; Zucchi R; Mavelli I; Contessi S Br J Pharmacol; 2012 Aug; 166(8):2331-47. PubMed ID: 22452346 [TBL] [Abstract][Full Text] [Related]
9. Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure. la Cour JL; Christensen HM; Köhrle J; Lehmphul I; Kistorp C; Nygaard B; Faber J J Clin Endocrinol Metab; 2019 Apr; 104(4):1232-1238. PubMed ID: 30383216 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold. Manni ME; De Siena G; Saba A; Marchini M; Landucci E; Gerace E; Zazzeri M; Musilli C; Pellegrini-Giampietro D; Matucci R; Zucchi R; Raimondi L Br J Pharmacol; 2013 Jan; 168(2):354-62. PubMed ID: 22889145 [TBL] [Abstract][Full Text] [Related]
11. Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides. Ronkainen JJ; Vuolteenaho O; Tavi P Endocrinology; 2007 Jun; 148(6):2815-20. PubMed ID: 17332063 [TBL] [Abstract][Full Text] [Related]
12. Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling. Hall EJ; Pal S; Glennon MS; Shridhar P; Satterfield SL; Weber B; Zhang Q; Salama G; Lal H; Becker JR Cardiovasc Res; 2022 Jul; 118(9):2124-2138. PubMed ID: 34329394 [TBL] [Abstract][Full Text] [Related]
13. Effects of acute microinjections of the thyroid hormone derivative 3-iodothyronamine to the preoptic region of adult male rats on sleep, thermoregulation and motor activity. James TD; Moffett SX; Scanlan TS; Martin JV Horm Behav; 2013 Jun; 64(1):81-8. PubMed ID: 23702093 [TBL] [Abstract][Full Text] [Related]
14. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors. Biebermann H; Kleinau G Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479 [TBL] [Abstract][Full Text] [Related]
15. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism. Lehmphul I; Hoefig CS; Köhrle J Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352 [TBL] [Abstract][Full Text] [Related]
16. 3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors. Laurino A; Matucci R; Vistoli G; Raimondi L Eur J Pharmacol; 2016 Dec; 793():35-42. PubMed ID: 27815171 [TBL] [Abstract][Full Text] [Related]
18. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926 [No Abstract] [Full Text] [Related]
19. Determination of 3-iodothyronamine (3-T Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577 [TBL] [Abstract][Full Text] [Related]
20. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine. Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]